
No partnership between Apollo.io and the American Cancer Society (ACS) is currently announced. This article is a due-diligence framework for GTM and revenue leaders evaluating what a privacy-first, corporate-account-only pilot between a sales intelligence platform and a national nonprofit could look like, and what guardrails would need to exist before any data ever moves.
Apollo.io is a go-to-market platform used by Sales Professionals, SDRs/BDRs, AEs, RevOps, marketing, and revenue leaders to find and engage business contacts. It is not a donor database, a patient registry, or a fundraising CRM. Any exploration of an ACS relationship has to start from that distinction, since ACS's own corporate partnership page is built around brand alignment and philanthropic contribution, not B2B contact licensing.

Still spending hours a day chasing down emails and phone numbers that bounce anyway? Apollo hands your team verified contact data instantly, with 98% email accuracy built in. Give reps back their selling time and let Apollo do the digging.
Start Free with Apollo →The opportunity is a hypothetical corporate-partnership prospecting pilot, not a data-sharing deal. ACS raises substantial corporate support each year, and a sales intelligence platform like Apollo could theoretically help ACS's partnership team identify, segment, and prioritize prospective corporate sponsors, employer partners, and cause-marketing accounts.
Apollo's database includes 240M+ People and 30M+ Companies with 98% email accuracy, and it's used by 600K+ companies. For a nonprofit partnership team, that scale matters only if it's applied to corporate accounts, industries, and giving history, never to individual patients or donors.
ACS already runs partnership tiers covering mission-impact programs, employee engagement, cause marketing, and sponsorship, similar to the model described on its become-a-partner page. An Apollo-enabled workflow would sit upstream of that: helping identify which companies to approach, not managing the relationship once signed.
The corporate giving market makes this timely because it's large, growing, and still underused by most nonprofits as a strategic channel. According to Business Initiative, corporate donations grew 9.1% to $44.4 billion in 2024.
That growth trend gives nonprofit partnership teams a reason to invest in better account targeting rather than relying on inbound relationships alone. ACS's brand strength adds to the case: ACS maintains 94% brand recognition, according to the American Cancer Society's own partnership page.
A recognizable brand paired with a systematic account-identification process is a stronger pitch to corporate prospects than either element alone.
For Revenue Leaders and RevOps professionals evaluating this kind of pilot internally, the math is straightforward: if corporate giving is growing faster than most other funding lines, the teams that build repeatable account-prioritization processes will capture disproportionate share. That's the same logic B2B sales teams apply to pipeline building in any other vertical.

A data governance firewall would need to exclude every constituent-level record from the prospecting workflow while still allowing corporate-account research. ACS has been explicit that it does not sell, loan, or distribute its mailing lists or email addresses, and that policy has to extend to any prospecting tool a partnership team adopts.
| Data Category | Allowed in Apollo Workflow? | Rationale |
|---|---|---|
| Corporate contact names, titles, company domains | Yes | Public B2B business contact information, standard sales intelligence use case |
| Company firmographics (industry, headcount, HQ location) | Yes | Used for account segmentation and prioritization only |
| Prior corporate giving or sponsorship history | Yes, if sourced from public filings | Supports account scoring; not personal data |
| Individual donor names or emails | No | ACS constituent data, never exported to a third-party platform |
| Patient, caregiver, or survivor records | No | Protected health-adjacent data, zero tolerance for third-party exposure |
| ACS internal mailing lists | No | ACS policy explicitly prohibits distribution of these lists |
This table is the starting point for any legal and RevOps review, not a substitute for one. LiveRamp's case study on ACS describes an initiative focused on bridging fragmented data for "data-driven acquisition," underscoring that ACS has precedent for structured data partnerships when the use case and boundaries are clearly defined.
Marketing leads pile up but never turn into real opportunities? Apollo surfaces buying signals and intent data so reps chase prospects who are actually ready to talk. Built-In used Apollo's scoring to lift win rates and deal size.
Start Free with Apollo →A 90-day pilot would work by testing a narrow, human-reviewed corporate-account workflow before any broader rollout. The goal is to prove the model on a small, controlled scope, not to launch full-scale outbound.
Struggling to keep a pilot this structured from sprawling into scattered spreadsheets? Centralizing account research and outreach in Apollo's sales engagement platform keeps every touchpoint auditable in one workspace.
The KPIs that should define success combine standard sales metrics with mission-relevant outcomes, since a nonprofit pilot can't be judged on meeting volume alone.
| Metric | What It Measures | Go Signal |
|---|---|---|
| Qualified partner opportunities identified | Account-list quality | Meaningful share of accounts match ICP criteria |
| Meetings booked | Outreach effectiveness | Measurable increase over baseline manual prospecting |
| Data firewall violations | Governance compliance | Zero violations, no exceptions |
| Signed partnerships or LOIs | Pipeline conversion | At least one advances to a formal proposal stage |
| Internal team confidence (survey) | Adoption readiness | Partnership team reports the workflow saved research time |
A single firewall violation, even a minor one, should be an automatic no-go. Everything else on this table is a matter of degree; the firewall metric is binary.
RevOps and partnership teams can apply this model to other nonprofit deals by treating account-based prospecting and constituent-data protection as two separate systems that never intersect. This is the same discipline B2B RevOps leaders already apply when segmenting buyer leads from unrelated contact lists.
For Sales Leaders and RevOps professionals running this kind of evaluation, the underlying lesson is tool consolidation. Instead of stitching together a separate prospecting tool, a separate enrichment vendor, and a separate outreach platform, Apollo's data enrichment and engagement features live in one workspace. As Collin Stewart of Predictable Revenue put it, "We reduced the complexity of three tools into one."
For SDRs and partnership associates doing the day-to-day account research, that consolidation means less time switching between systems and more time on outreach quality. RevOps leaders evaluating a similar pilot for their own nonprofit or B2B2C partnerships should also review Apollo's CRM integrations to confirm data stays synced without duplicating constituent records.
No. Apollo's database is built from business contact information, and any responsible partnership model would exclude ACS donor, patient, caregiver, and survivor records entirely.
ACS has stated it does not sell, loan, or distribute its mailing lists or email addresses, and that boundary would need to be a contractual requirement, not just a best practice.
Apollo.io combines contact search, enrichment, and outreach execution in one platform, while Sales Navigator is primarily a research and lead-list tool that typically requires a separate engagement platform. For a nonprofit partnership team, that difference matters because it reduces the number of vendors touching account data. See how the two compare in Apollo's alternatives breakdown.
Any pilot would need to sync corporate-account data, not constituent data, into ACS's existing CRM through a controlled integration. Apollo supports standard CRM sync patterns already used by RevOps teams managing deal pipelines, but the integration scope should be defined and reviewed before any data flows.
No. This article is an evaluative framework for GTM and nonprofit partnership professionals, not an announcement of any agreement between Apollo.io and the American Cancer Society.

A corporate-partnership pilot between a sales intelligence platform and a nonprofit like ACS is a reasonable idea in theory, but it only works with a firewall that never lets constituent data anywhere near a B2B prospecting tool. The framework above, governance matrix, 90-day pilot, and go/no-go criteria, gives any RevOps or partnership team a starting point for that evaluation.
If your team is building or refining its own corporate-account prospecting motion, whether for nonprofit partnerships or standard B2B pipeline, Apollo's go-to-market platform consolidates the research, enrichment, and outreach steps into one system. Request a Demo to see how Apollo handles account-based prospecting responsibly: Request a Demo.
Struggling to justify tool spend before the trial period even ends? Apollo replaces scattered manual outreach with one platform reps adopt in days, not quarters. Leadium tripled annual revenue by automating outbound and speeding follow-up.
Start Free with Apollo →Sales
Inbound vs Outbound Marketing: Which Strategy Wins?
Sales
What Is a Sales Funnel? The Non-Linear Revenue Framework for 2026
Sales
What Is a Go-to-Market Strategy? The 2026 GTM Playbook
We'd love to show how Apollo can help you sell better.
By submitting this form, you will receive information, tips, and promotions from Apollo. To learn more, see our Privacy Statement.
4.7/5 based on 9,690 reviews
